As tariffs, HHS workforce cuts and the ouster of CBER Director Peter Marks threaten the “lifeblood” of the cell and gene ...

In advanced head and neck squamous cell carcinoma, evorpacept and Keytruda didn’t meet the primary endpoints of the ASPEN-03 ...

The Trump administration has announced that it will use emergency authorities to rapidly increase the pace of approving fossil fuel and mining projects on public lands. The Interior Department ...

Novavax says its closely watched COVID-19 vaccine is on track for full U.S. approval after additional discussions with the ...

PBGENE-HBV is designed to potentially cure chronic hepatitis B by eliminating the root cause of the virus. The Food and Drug Administration (FDA) has granted Fast Track designation to PBGENE-HBV, an ...

The movie Limitless (2011) featured Bradley Cooper in his first dramatic starring role as Eddie Morra, a struggling writer ...

The AI model, called Damo Panda, was designed to detect early-stage pancreatic cancer using deep learning and abdominal CT ...

The US Food and Drug Administration (FDA) has awarded breakthrough therapy designation to uniQure's AMT-130 for treating ...

VERV’s VERVE-102 showed an impressive 69% LDL-C reduction in its early Phase 1b data. Click here to find out why I rate VERV ...

Shares of Precision BioSciences DTIL rallied 23.8% on Tuesday after the company’s announcement that the FDA has granted Fast Track designation to PBGENE-HBV. This is DTIL’s lead, fully owned in vivo ...

Precision BioSciences (DTIL) announced that the FDA has granted fast track designation for PBGENE-HBV, the company’s lead wholly owned in vivo ...

BOSTON - The U.S. Food and Drug Administration (FDA) has awarded Fast Track designation to Verve Therapeutics’ (NASDAQ:VERV) VERVE-102, a gene-editing treatment aimed at patients with hyperlipidemia ...